Dr Phil McElnay

Dr. Phil McElnay is an accomplished healthcare professional with extensive experience in various leadership roles. Currently serving as CEO at MedAll since July 2017, Dr. McElnay leads a global network connecting healthcare professionals and medical organizations, facilitating access to quality content and education. Additionally, Dr. McElnay holds the position of NHS Clinical Entrepreneur and serves on the editorial board of the Annals of Translational Medicine. Previous roles include Medical Director at GSK, Journal and News Scan Editor at CTSNet, and contributions to the International Guidelines Committee for Mesothelioma with the European Respiratory Society. Dr. McElnay's educational background includes a Bachelor of Medicine, Master of Science degrees in Clinical Research and Medical Education, and a diploma from the Royal College of Surgeons.